Effectiveness and Safety of Angongniuhuang Pill on Restoring Consciousness for Patients Who Have Suffered From a Stroke
Status and phase
Conditions
Treatments
Details and patient eligibility
About
This study will determine if Angongniuhuang Pill (Composed of Niuhuang, Yujin, Xijiao, Huangqin, Huanglian, Xionghuang, Zhizi, Zhusha, Bingpian, Shexiang, and Zhenzhu) will have a better effect in restoring consciousness for patients who have suffered from an acute ischemic stroke. The study is designed to look at both consciousness level and overall recovery and recovery of motor function, for example muscle strength and coordination.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Occurrence of an acute ischemic stroke (between 9 and 72 h after onset) with
- A score of not higher than 12 of Glasgow Coma Scale (GCS)
- Patient age of between 18 and 80 years.
- Patients or their representatives voluntarily take part in this study and signed the informed consent
Exclusion criteria
- Transient Ischemic attack(TIA), cerebral hemorrhage, subarachnoid hemorrhage
- Ischemic stroke that needs rt-PA treatment
- Subjects who are unlikely to complete taking the investigational product and/or are unlikely to undergo active medical management during that period due to a severe clinical condition.
- Pregnant or breast-feeding.
- Proven disability by law, such as blindness, deafness, dumb, disturbance of intelligence, mental disorders, limb handicap.
- Liable to be allergic (allergic to at lease 2 foods/drugs previously exposed)
- Had been participated in other clinical trials during the last 1 month prior to study inclusion.
Trial design
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Central trial contact
Dingfang Cai, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal